HMGB3

From WikiMD's Food, Medicine & Wellness Encyclopedia

HMGB3 (High Mobility Group Box 3) is a protein that in humans is encoded by the HMGB3 gene. This protein belongs to the high mobility group (HMG) box family of non-histone proteins, which are involved in chromatin architecture and function. HMGB3 plays a critical role in the regulation of gene expression, DNA repair, and cell differentiation. It is particularly important during early embryonic development and has been studied for its role in stem cell maintenance and differentiation.

Function[edit | edit source]

HMGB3, like other members of the HMG-box family, binds to DNA in a non-sequence-specific manner. It can bend DNA and, thereby, influence the assembly of nucleoprotein complexes. This ability makes it an essential player in processes such as transcription, nucleosome positioning, and the loading of transcription factors onto DNA. HMGB3 has been implicated in the regulation of gene expression by modulating the chromatin structure, making it more accessible to transcription factors and other regulatory proteins.

In addition to its role in gene expression, HMGB3 is involved in the cellular response to DNA damage. It participates in the repair process by recognizing and binding to damaged DNA, facilitating the recruitment of other DNA repair proteins to the site of damage. This function is crucial for maintaining genomic stability and preventing mutations that could lead to diseases such as cancer.

Clinical Significance[edit | edit source]

Alterations in the expression levels of HMGB3 have been associated with various types of cancer, including breast cancer, leukemia, and gastric cancer. Overexpression of HMGB3 has been observed in tumor tissues compared to normal tissues, suggesting its role in tumorigenesis. It is believed that HMGB3 may contribute to cancer development by promoting cell proliferation, inhibiting apoptosis (programmed cell death), and enhancing the metastatic potential of cancer cells.

Given its involvement in cancer, HMGB3 is being studied as a potential target for cancer therapy. Inhibiting the function of HMGB3 could suppress tumor growth and progression, offering a novel approach to cancer treatment. However, more research is needed to fully understand its mechanisms of action and to develop effective strategies for targeting HMGB3 in cancer.

Expression and Regulation[edit | edit source]

The expression of HMGB3 is tightly regulated and varies among different tissues and developmental stages. It is highly expressed in embryonic tissues and some adult stem cells, indicating its importance in development and stem cell function. The regulation of HMGB3 expression involves various transcription factors, epigenetic mechanisms, and microRNAs that can either promote or suppress its transcription.

See Also[edit | edit source]


Wiki.png

Navigation: Wellness - Encyclopedia - Health topics - Disease Index‏‎ - Drugs - World Directory - Gray's Anatomy - Keto diet - Recipes

Search WikiMD


Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro) available.
Advertise on WikiMD

WikiMD is not a substitute for professional medical advice. See full disclaimer.

Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.


Contributors: Prab R. Tumpati, MD